Palaniyandi T, K B, Prabhakaran P, Viswanathan S, Rahaman Abdul Wahab M, Natarajan S, et al. Nanosensors for the diagnosis and therapy of neurodegenerative disorders and inflammatory bowel disease. Acta Histochem. 2023;125:151997.

Article  CAS  PubMed  Google Scholar 

Gao H-M, Hong J-S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29:357–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thabitha A, Vignesh N, Saravanan R. Nutrients’ role in the treatment of Parkinson’s and Alzheimer’s diseases. 2022. p. 237–46.

Jain N, Chen-Plotkin AS. Genetic modifiers in neurodegeneration. Curr Genet Med Rep. 2018;6:11–9.

Article  PubMed  PubMed Central  Google Scholar 

Wareham LK, Liddelow SA, Temple S, Benowitz LI, Di Polo A, Wellington C, et al. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegener. 2022;17:23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovacs GG. Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol. 2019;72:725–35.

Article  CAS  PubMed  Google Scholar 

Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23.https://doi.org/10.3390/ijms23031851

Mukherjee S, Madamsetty VS, Bhattacharya D, Roy Chowdhury S, Paul MK, Mukherjee A. Recent advancements of nanomedicine in neurodegenerative disorders theranostics. Adv Funct Mater. 2020;30:2003054.

Sheikh S, Safia, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013;2013:1–8.

Han F, Wang J, Ding L, Hu Y, Li W, Yuan Z, et al. Tissue engineering and regenerative medicine: achievements, future, and sustainability in Asia. Front Bioeng Biotechnol. 2020;8:83.

Krishani M, Shin WY, Suhaimi H, Sambudi NS. Development of scaffolds from bio-based natural materials for tissue regeneration applications: a review. Gels. 2023;9:100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willerth SM, Sakiyama-Elbert SE. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev. 2007;59:325–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uz M, Mallapragada SK. Conductive polymers and hydrogels for neural tissue engineering. J Indian Inst Sci. 2019;99:489–510.

Article  Google Scholar 

Rahman MdM, Islam MdR, Yamin Md, Islam MdM, Sarker MdT, Meem AFK, et al. Emerging role of neuron-glia in neurological disorders: at a glance. Oxid Med Cell Longev. 2022;2022:1–27.

Das S, Sharma M, Saharia D, Sarma KK, Sarma MG, Borthakur BB, et al. In vivo studies of silk based gold nano-composite conduits for functional peripheral nerve regeneration. Biomaterials. 2015;62:66–75.

Article  CAS  PubMed  Google Scholar 

Zarrintaj P, Zangene E, Manouchehri S, Amirabad LM, Baheiraei N, Hadjighasem MR, et al. Conductive biomaterials as nerve conduits: recent advances and future challenges. Appl Mater Today. 2020;20: 100784.

Article  Google Scholar 

Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, et al. Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev. 2024;99: 102357.

Article  CAS  PubMed  Google Scholar 

Williams NP, Kushwah N, Dhawan V, Zheng XS, Cui XT. Effects of central nervous system electrical stimulation on non-neuronal cells. Front Neurosci. 2022;16:967491.

Sheppard O, Coleman M. Alzheimer’s disease: etiology, neuropathology and pathogenesis. Alzheimer’s disease: drug discovery. Exon Publications; 2020. pp. 1–21.

Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157–72.

Article  PubMed  Google Scholar 

Scheckel C, Aguzzi A. Prions, prionoids and protein misfolding disorders. Nat Rev Genet. 2018;19:405–18.

Article  CAS  PubMed  Google Scholar 

Baiardi S, Mammana A, Capellari S, Parchi P. Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies. Expert Opin Ther Targets. 2023;27:1271–84.

Article  CAS  PubMed  Google Scholar 

Ritchie DL, Barria MA. Prion diseases: a unique transmissible agent or a model for neurodegenerative diseases? Biomolecules. 2021;11:207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kodavati M, Wang H, Hegde ML. Altered mitochondrial dynamics in motor neuron disease: an emerging perspective. Cells. 2020;9: 1065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zucchi E, Bonetto V, Sorarù G, Martinelli I, Parchi P, Liguori R, et al. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener. 2020;15:58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gittings LM, Sattler R. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies. Fac Rev. 2020;9:9.

Article  Google Scholar 

Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22:185–212.

Article  CAS  PubMed  Google Scholar 

Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20:385–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee TK, Yankee EL. A review on Parkinson’s disease treatment. Neuroimmunol Neuroinflamm. 2022;8:222.

Article  Google Scholar 

Anirudhan A, Mahema S, Ahmad SF, Bin Emran T, Ahmed SSSJ, Paramasivam P. Screening of crucial cytosolicproteins interconnecting the endoplasmic reticulum and mitochondria in Parkinson’s disease and the impact of anti-Parkinson drugs in the preservation of organelle connectivity. Brain Sci. 2023;13:1551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chia SJ, Tan E-K, Chao Y-X. Historical perspective: models of Parkinson’s disease. Int J Mol Sci. 2020;21: 2464.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roos RA. Huntington’s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.

Article  PubMed  PubMed Central  Google Scholar 

Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Huntington’s disease: diagnosis and management. Pract Neurol. 2022;22:32–41.

Article  PubMed  Google Scholar 

Pan L, Feigin A. Huntington’s disease: new frontiers in therapeutics. Curr Neurol Neurosci Rep. 2021;21:10.

Article  PubMed  Google Scholar 

Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8:52.

Article  PubMed  Google Scholar 

Keinath MC, Prior DE, Prior TW. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl Clin Genet. 2021;14:11–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Messina S, Sframeli M. New treatments in spinal muscular atrophy: positive results and new challenges. J Clin Med. 2020;9:2222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boni R, Ali A, Shavandi A, Clarkson AN. Current and novel polymeric biomaterials for neural tissue engineering. J Biomed Sci. 2018;25:90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang W-H, Di